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Resistant hypertension (RH) is an important cause of cardiovascular mor-
bidity and mortality. Both true and pseudo-resistant arterial hypertension
(AH) represent a big problem not only in blood pressure (BP) control, but
also in those possible adverse cardiovascular events, the development of
which is associated with failure to achieve target BP levels.
The aim of the study was to establish the features of hemodynamic and
metabolic parameters in obese patients with true and pseudo-resistant AH.
Material and methods: The study included 200 patients with uncontrolled
AH and obesity. Patients were initially prescribed dual antihypertensive
therapy. Those patients who did not reach target BP levels after 3 months
on dual therapy were additionally assigned a third antihypertensive drug.
Of the 98 patients who were assigned triple therapy, 48 patients did not
reach target BP (27 patients had pseudo-resistant and 21 patients had true
resistant AH). These patients were additionally prescribed a fourth antihy-
pertensive drug (spironolactone). The effectiveness of the treatment was
evaluated 6 months after the start of antihypertensive therapy.
Results: After 6 months of therapy, patients with RH had higher body
mass index (BMI) and higher BP levels compared to patients without this
condition. Patients with RH also had more pronounced cardiovascular re-
modeling, higher levels of triglycerides, insulin, HbA1c, more pronounced
insulin resistant (IR), which was confirmed by greater HOMA-IR, greater
imbalance of adipokines, proinflamation activity and higher activity of the
renin-angiotensin-aldosterone system (RAAS). A comparative assessment
of pseudo-resistance and true resistance showed that patients with true re-
sistance differed from pseudo-resistant patients with significantly lower BMI
(p=0.02). In addition, in the absence of differences in BP levels, cardiovas-
cular remodeling, lipid and carbohydrate profiles, patients with true resis-
tance had significantly higher levels of aldosterone (p=0.04), higher activ-
ity of oxidative stress (malonic dialdehyde, p=0.01 and diene conjugates,
p=0.03), a lower level of total antioxidant protection (p=0.00), a higher level
of adiponectin (p=0.00), and a lower level of leptin (p=0.00), compared with
pseudo-resistant patients.
Conclusions: Patients with resistant hypertension differed from hyperten-
sive obese patients without resistance with higher BMI and BP, higher lev-
els of triglycerides, insulin, HbA1c, more pronounced IR, cardiovascular
remodeling, imbalance of oxidative stress - antioxidant protection system,
higher proinflammatory and RAAS activity. Patients with true resistance
differed from pseudo-resistant patients with significantly lower BMI, higher
aldosterone levels, more pronounced imbalance of the system of oxidative
stress - antioxidant protection and less pronounced adipokines imbalance.
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